HighTide Therapeutics, Inc. - B Stock: price and insider trades · Hong Kong

HighTide Therapeutics, Inc. - B is a Health Care company. Its directors and officers file their transactions with HKEX. In the past year (22 October 2025 to 22 October 2026), 10 filings came from 4 insiders.

No insider bought on the market over the period, while 3 insiders filed 3 sales. The totals exclude 3 filings filed without an amount.

Filings reach the HKEX feed a median of 7 days after the trade. Until a filing is published, the market cannot know about the trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

For context, the typical company on the same exchange (median of 1,314 companies) published 4 filings over the same period, against 10 filings here. Over the whole record (from 2024), the tally stands at no purchases and 4 sales.

In the same sector, recent insider purchases at UCB also feature in our signals. Source: insider filings from HKEX. Past trades are no guide to future returns.